Avenue Therapeutics, Inc. (ATXI) stock
ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.43+0.00 (0.00%)
Close on Oct 16, 2026Market cap $1.42MP/E –Yield –
Avenue Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Avenue Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $1.40M. For fiscal 2025 it was $1.40M.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.40M | – |
| FY2024 | Dec 31, 2024 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q4 FY2025 | Dec 31, 2025 | $0 | – |
| Q3 FY2025 | Sep 30, 2025 | $0 | – |
| Q2 FY2025 | Jun 30, 2025 | $1.40M | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024 | Jun 30, 2024 | $0 | – |
See a number that looks wrong?